6-(4-BROMOPHENYL)IMIDAZO[2,1-B]THIAZOLE, 97.0%, 5g

Ácido de tungsteno, mínimo 99 %, pa, 25 g, envase de plástico.

4-Bromo-2-methylbenzonitrile>98.0%(GC)5g

Columna capilar GC ROTI®Cap-1701 MS, 60 m, 0,25 mm, 0,50 µm, 1 Pieza(s)

2-(Diethylcarbamoyl)-3,6-difluorobenzoic acid, 98%, 250mg

(S)-2-Morpholin-4-yl-propionic acid hydrochloride, 97%, 1g

4-(Trifluoromethyl)bicyclo[2.2.2]octane-1-carboxylic acid, 98%, 100mg

4-Bromo-3-chloro-2-fluoroiodobenzene, 97.0%, 25g

N-(5-((2R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-3-nitro-6-(4-nitrophenethoxy)pyridin-2-yl)acetamide, 98%, 250mg

2-Chloro-4-methylbenzaldehyde, 97.0%, 5g

1,3-Dimethyl-1,1,3,3-tetraphenyldisilazane>95.0%(GC)5g

{4H,5H,6H,7H-pyrazolo[1,5-a]pyrazin-2-yl}methanol, 97%, 10g

Ethyl 2-(methylthio)pyrimidine-4-carboxylate, 95.0%, 100mg